Dietary monoglyceride supplementation to support intestinal integrity and host defenses in health-challenged weanling pigs
Journal of Animal Science · 03.01.2024 · 102
DOI: 10.1093/jas/skae105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Animal Science, online erschienen am 17.04.2024. Verfasst von Cameron S White und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences, University of Illinois, Urbana, IL, USA. Hauptthemen laut MEDLINE: Swine Diseases, Escherichia coli Infections, Dietary Supplements, Monoglycerides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Frequent incidence of postweaning enterotoxigenic Escherichia coli (ETEC) diarrhea in the swine industry contributes to high mortality rates and associated economic losses. In this study, a combination of butyric, caprylic, and capric fatty acid monoglycerides was investigated to promote intestinal integrity and host defenses in weanling pigs infected with ETEC. A total of 160 pigs were allotted to treatment groups based on weight and sex. Throughout the 17-d study, three treatment groups were maintained: sham-inoculated pigs fed a control diet (uninfected control [UC], n = 40), ETEC-inoculated pigs fed the same control diet (infected control [IC], n = 60), and ETEC-inoculated pigs fed the control diet supplemented with monoglycerides included at 0.3% of the diet (infected supplemented [MG], n = 60). After a 7-d acclimation period, pigs were orally inoculated on each of three consecutive days with either 3 mL of a sham-control (saline) or live ETEC culture (3 × 109 colony-forming units/mL). The first day of inoculations was designated as 0 d postinoculation (DPI), and all study outcomes reference this time point. Fecal, tissue, and blood samples were collected from 48 individual pigs (UC, n = 12; IC, n = 18; MG, n = 18) on 5 and 10 DPI for analysis of dry matter (DM), bacterial enumeration, inflammatory markers, and intestinal permeability. ETEC-inoculated pigs in both the IC and MG groups exhibited clear signs of infection including lower (P < 0.05) gain:feed and fecal DM, indicative of excess water in the feces, and elevated (P < 0.05) rectal temperatures, total bacteria, total E. coli, and total F18 ETEC during the peak-infection period (5 DPI). Reduced (P < 0.05) expression of the occludin, tumor necrosis factor α, and vascular endothelial growth factor A genes was observed in both ETEC-inoculated groups at the 5 DPI time point. There were no meaningful differences between treatments for any of the outcomes measured at 10 DPI. Overall, all significant changes were the result of the ETEC infection, not monoglyceride supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Sciences, University of Illinois, Urbana, IL, USA.
- Veterinary Diagnostic Laboratory, University of Illinois, Urbana, IL, USA.
- BASF SE, Ludwigshafen, Germany.
ORCID-Profile: Ryan N Dilger
Zitieren
APA
White, C. S., Hung, C. C., Lanka, S., Maddox, C. W., Barri, A., Sokale, A. O., & Dilger, R. N. (2024). Dietary monoglyceride supplementation to support intestinal integrity and host defenses in health-challenged weanling pigs. Journal of Animal Science, 102. https://doi.org/10.1093/jas/skae105
Vancouver
White CS, Hung CC, Lanka S, Maddox CW, Barri A, Sokale AO, et al. Dietary monoglyceride supplementation to support intestinal integrity and host defenses in health-challenged weanling pigs. Journal of Animal Science. 2024;102. doi:10.1093/jas/skae105
BibTeX
@article{White2024,
author = {White, Cameron S and Hung, Chien-Che and Lanka, Saraswathi and Maddox, Carol W and Barri, Adriana and Sokale, Adebayo O and Dilger, Ryan N},
title = {Dietary monoglyceride supplementation to support intestinal integrity and host defenses in health-challenged weanling pigs},
journal = {Journal of Animal Science},
year = {2024},
volume = {102},
doi = {10.1093/jas/skae105}
}
EUVIMED